N. Mortensen

发表

A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis

Demin Li, Francesca M. Buffa, Roger Patient, 2013, Cancer cell.

Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer.

A. Harris, N. Mortensen, K. Gatter, 1992, British Journal of Cancer.

Loss of HLA class‐I alleles, heavy chains and β2‐microglobulin in colorectal cancer

A. Harris, J. Bodmer, W. Bodmer, 1992, International journal of cancer.

Humanised IgG1 antibody variants targeting membrane-bound carcinoembryonic antigen by antibody-dependent cellular cytotoxicity and phagocytosis

W. Bodmer, J. Wilding, N. Mortensen, 2009, British Journal of Cancer.

Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer.

A. Harris, K. Gatter, I. Doussis-Anagnostopoulou, 1998, British Journal of Cancer.

Targeted killing of colorectal cancer cell lines by a humanised IgG1 monoclonal antibody that binds to membrane-bound carcinoembryonic antigen

W. Bodmer, J. Wilding, D. Bicknell, 2008, British Journal of Cancer.

A case‐control study of colorectal cancer detection by quantification of DNA isolated from directly collected exfoliated colonocytes

B. George, N. Mortensen, A. Loktionov, 2010, International journal of cancer.

Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer.

A. Harris, I. Doussis-Anagnostopoulou, A. Townsend, 1994, The American journal of pathology.

EARLY EXPRESSION OF bcl‐2 PROTEIN IN THE ADENOMA–CARCINOMA SEQUENCE OF COLORECTAL NEOPLASIA

A. Harris, K. Gatter, I. Doussis-Anagnostopoulou, 1996, The Journal of pathology.

CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability.

O. Sieber, S. Halford, I. Tomlinson, 2005, Cancer research.

p53 expression in colorectal adenomas.

A. Harris, D. Lane, N. Mortensen, 1993, The American journal of pathology.

Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer

S. Fox, A. Harris, A. Jubb, 2009, British Journal of Cancer.

Direct and immune mediated antibody targeting of ERBB receptors in a colorectal cancer cell-line panel

W. Bodmer, J. Wilding, N. Mortensen, 2012, Proceedings of the National Academy of Sciences.

Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer

W. Bodmer, J. Efstathiou, M. Ilyas, 2001, Gut.

Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1.

W. Bodmer, I. Tomlinson, N. E. Beck, 1999, Proceedings of the National Academy of Sciences of the United States of America.

An insight into the genetic pathway of adenocarcinoma of the small intestine

W. Bodmer, N. Shepherd, B. Warren, 2002, Gut.

Myofibroblast activation in colorectal cancer lymph node metastases

C. Buskens, W. Bodmer, Lung-Chuang Wang, 2013, British Journal of Cancer.

Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer.

A. Harris, N. Mortensen, K. Gatter, 1992, British Journal of Cancer.

EARLY EXPRESSION OF bcl‐2 PROTEIN IN THE ADENOMA–CARCINOMA SEQUENCE OF COLORECTAL NEOPLASIA

A. Harris, K. Gatter, I. Doussis-Anagnostopoulou, 1996, The Journal of pathology.

Expression of colonic antigens by goblet and columnar epithelial cells in ileal pouch mucosa: their association with inflammatory change and faecal stasis.

D. Jewell, N. Mortensen, N. Mortensen, 1994, Journal of clinical pathology.